Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)

Cardona, Andrés F.; Ávila, Vaneza; Arrieta, Oscar

doi:10.36401/JIPO-23-22

Article navigation

letter| October 31 2023

Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)

Andrés F. Cardona;

Andrés F. Cardona

¹Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia

²GIGA Research Group, Universidad El Bosque, Bogotá, Colombia

³Direction of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia

Address correspondence to Andrés F. Cardona (acardona@fctic.org).

Search for other works by this author on:

This Site

PubMed

Google Scholar

Vaneza Ávila;

Vaneza Ávila

¹Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia

Search for other works by this author on:

This Site

PubMed

Google Scholar

Oscar Arrieta

⁴Thoracic Oncology Unit, National Cancer Institute (INCan), México City, México

Search for other works by this author on:

This Site

PubMed

Google Scholar

Journal of Immunotherapy and Precision Oncology (2023)

https://doi.org/10.36401/JIPO-23-22

Send Email

Recipient(s) will receive an email with a link to 'Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)' and will not need an account to access the content.

*Your Name:

*Your Email Address:

CC:

*Recipient 1:

Recipient 2:

Recipient 3:

Recipient 4:

Recipient 5:

Subject: Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)

Optional Message:

(Optional message may have a maximum of 1000 characters.)

Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)

Competing Interests

Article PDF first page preview

Citing articles via

Get Email Alerts

Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)

Competing Interests

Article PDF first page preview

Send Email

Citing articles via

Get Email Alerts

This Feature Is Available To Subscribers Only